Epigenetic silencing of olfactomedin-4 enhances gastric cancer cell invasion via activation of focal adhesion kinase signaling |
Guo, Li-Li
(Department of Gastroenterology, Heping Hospital, Changzhi Medical College)
He, Zhao-Cai (Department of General Surgery, Heping Hospital, Changzhi Medical College) Yang, Chang-Qing (Department of Gastroenterology, Heping Hospital, Changzhi Medical College) Qiao, Pei-Tang (Department of Gastroenterology, Heping Hospital, Changzhi Medical College) Yin, Guo-Ling (Department of radiotherapy, Heping Hospital, Changzhi Medical College) |
1 | Clemmensen SN, Bohr CT, Rorvig S et al (2012) Olfactomedin 4 defines a subset of human neutrophils. J Leukoc Biol 91, 495-500 DOI |
2 | Chin KL, Aerbajinai W, Zhu J et al (2008) The regulation of OLFM4 expression in myeloid precursor cells relies on NF-kappaB transcription factor. Br J Haematol 143, 421-432 DOI |
3 | Sun F, Peatman E, Li C et al (2012) Transcriptomic signatures of attachment, NF-kappaB suppression and IFN stimulation in the catfish gill following columnaris bacterial infection. Dev Comp Immunol 38, 169-180 DOI |
4 | Grover PK, Hardingham JE, Cummins AG (2010) Stem cell marker olfactomedin 4: critical appraisal of its characteristics and role in tumorigenesis. Cancer Metastasis Rev 29, 761-775 DOI |
5 | Besson D, Pavageau AH, Valo I et al (2011) A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor marker. Mol Cell Proteomics 10, M111-M9712 DOI |
6 | Luo Z, Zhang Q, Zhao Z, Li B, Chen J, Wang Y (2011) OLFM4 is associated with lymph node metastasis and poor prognosis in patients with gastric cancer. J Cancer Res Clin Oncol 137, 1713-1720 DOI |
7 | Yu L, Wang L, Chen S (2011) Olfactomedin 4, a novel marker for the differentiation and progression of gastrointestinal cancers. Neoplasma 58, 9-13 DOI |
8 | Sampieri CL, Leon-Cordoba K, Remes-Troche JM (2013) Matrix metalloproteinases and their tissue inhibitors in gastric cancer as molecular markers. J Cancer Res Ther 9, 356-363 DOI |
9 | Jang BG, Lee BL, Kim WH (2015) Olfactomedin-related proteins 4 (OLFM4) expression is involved in early gastric carcinogenesis and of prognostic significance in advanced gastric cancer. Virchows Arch 467, 285-294 DOI |
10 | Yamanoi K, Arai E, Tian Y et al (2015) Epigenetic clustering of gastric carcinomas based on DNA methylation profiles at the precancerous stage: its correlation with tumor aggressiveness and patient outcome. Carcinogenesis 36, 509-520 DOI |
11 | Carneiro P, Figueiredo J, Bordeira-Carrico R et al (2013) Therapeutic targets associated to E-cadherin dysfunction in gastric cancer. Expert Opin Ther Targets 17, 1187-1201 DOI |
12 | Koshida S, Kobayashi D, Moriai R, Tsuji N, Watanabe N (2007) Specific overexpression of OLFM4(GW112/HGC-1) mRNA in colon, breast and lung cancer tissues detected using quantitative analysis. Cancer Sci 98, 315-320 DOI |
13 | Liu W, Zhu J, Cao L, Rodgers GP (2007) Expression of hGC-1 is correlated with differentiation of gastric carcinoma. Histopathology 51, 157-165 DOI |
14 | Oue N, Sentani K, Noguchi T et al (2009) Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients. Int J Cancer 125, 2383-2392 DOI |
15 | Suh YS, Lee HJ, Jung EJ et al (2012) The combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer. Ann Surg Oncol 19, 1240-1249 DOI |
16 | He D, Zhang YW, Zhang NN et al (2015) Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas. Med Oncol 32, 92 DOI |
17 | Zouridis H, Deng N, Ivanova T et al (2012) Methylation subtypes and large-scale epigenetic alterations in gastric cancer. Sci Transl Med 4, 140r-156r DOI |
18 | Dauksa A, Gulbinas A, Endzinas Z, Oldenburg J, El-Maarri O (2014) DNA methylation at selected CpG sites in peripheral blood leukocytes is predictive of gastric cancer. Anticancer Res 34, 5381-5388 |
19 | Du T, Qu Y, Li J et al (2014) Maternal embryonic leucine zipper kinase enhances gastric cancer progression via the FAK/Paxillin pathway. Mol Cancer 13, 100 DOI |
20 | Zhao C, Bu X (2012) Promoter methylation of tumor-related genes in gastric carcinogenesis. Histol Histopathol 27, 1271-1282 |
21 | Roberts WG, Ung E, Whalen P et al (2008) Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271. Cancer Res 68, 1935-1944 DOI |
22 | Mon NN, Ito S, Senga T, Hamaguchi M (2006) FAK signaling in neoplastic disorders: a linkage between inflammation and cancer. Ann N Y Acad Sci 1086, 199-212 DOI |
23 | Zhang J, Liu WL, Tang DC et al (2002) Identification and characterization of a novel member of olfactomedin-related protein family, hGC-1, expressed during myeloid lineage development. Gene 283, 83-93 DOI |
24 | Park KS, Kim KK, Piao ZH et al (2012) Olfactomedin 4 suppresses tumor growth and metastasis of mouse melanoma cells through downregulation of integrin and MMP genes. Mol Cells 34, 555-561 DOI |
25 | Liu RH, Yang MH, Xiang H et al (2012) Depletion of OLFM4 gene inhibits cell growth and increases sensitization to hydrogen peroxide and tumor necrosis factor-alpha induced-apoptosis in gastric cancer cells. J Biomed Sci 19, 38 DOI |